NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.900
-0.010 (-0.52%)
At close: Jan 21, 2025, 4:00 PM
1.910
+0.010 (0.53%)
Pre-market: Jan 22, 2025, 4:24 AM EST
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $3.08 million as of January 22, 2025. Its market cap has decreased by -83.03% in one year.
Market Cap
3.08M
Enterprise Value
4.24M
1-Year Change
-83.03%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $3.08M, a decrease of -84.68%. That is a compound annual growth rate of -37.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.10M | -9.48% |
| Dec 31, 2024 | 3.42M | -82.11% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |